<code id='ED0317D923'></code><style id='ED0317D923'></style>
    • <acronym id='ED0317D923'></acronym>
      <center id='ED0317D923'><center id='ED0317D923'><tfoot id='ED0317D923'></tfoot></center><abbr id='ED0317D923'><dir id='ED0317D923'><tfoot id='ED0317D923'></tfoot><noframes id='ED0317D923'>

    • <optgroup id='ED0317D923'><strike id='ED0317D923'><sup id='ED0317D923'></sup></strike><code id='ED0317D923'></code></optgroup>
        1. <b id='ED0317D923'><label id='ED0317D923'><select id='ED0317D923'><dt id='ED0317D923'><span id='ED0317D923'></span></dt></select></label></b><u id='ED0317D923'></u>
          <i id='ED0317D923'><strike id='ED0317D923'><tt id='ED0317D923'><pre id='ED0317D923'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:346
          Alastair Grant/AP

          LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

          The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

          advertisement

          AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing
          Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

          0:50AnelectronicsignadvertisestheMegaMillionsandPowerBalljackpotamountsoutsideaconveniencestoreonAug

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          The pain doctors face in trying to build their families

          Adobe“TheRetrievals,”adisturbingpodcastfromSerialandtheNewYorkTimesreleasedthissummer,painstakinglyt